Integra Lifesciences Holdings Stock Today
IART Stock | USD 29.38 0.40 1.38% |
Performance0 of 100
| Odds Of DistressLess than 1
|
Integra LifeSciences is selling for under 29.38 as of the 25th of April 2024; that is 1.38 percent increase since the beginning of the trading day. The stock's last reported lowest price was 28.97. Integra LifeSciences has a very small chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Integra LifeSciences Holdings are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 26th of March 2024 and ending today, the 25th of April 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 16th of August 1995 | Category Healthcare | Classification Health Care |
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey. The company has 78.6 M outstanding shares of which 2.09 M shares are currently shorted by private and institutional investors with about 2.27 trading days to cover. More on Integra LifeSciences Holdings
Moving together with Integra Stock
0.75 | UNH | UnitedHealth Group Financial Report 12th of July 2024 | PairCorr |
Moving against Integra Stock
0.82 | ELEV | Elevation Oncology Earnings Call This Week | PairCorr |
0.81 | AGTI | Agiliti Financial Report 14th of May 2024 | PairCorr |
0.75 | DSGN | Design Therapeutics Financial Report 14th of May 2024 | PairCorr |
0.72 | VKTX | Viking Therapeutics Potential Growth | PairCorr |
0.63 | NXL | Nexalin Technology | PairCorr |
0.54 | RCM | R1 RCM Inc Earnings Call This Week | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
Integra Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Integra LifeSciences' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Integra LifeSciences or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
CEO President | Jan Witte | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Thematic Ideas | (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, SP Midcap 400, NASDAQ Composite Total, NASDAQ Health Care, Obamacare Repeal, Baby Boomer Prospects, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Average Analyst Recommendation Analysts covering Integra LifeSciences report their recommendations after researching Integra LifeSciences' financial statements, talking to executives and customers, or listening in on Integra LifeSciences' conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Integra LifeSciences. The Integra consensus assessment is calculated by taking the average forecast from all of the analysts covering Integra LifeSciences. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength Based on the key indicators related to Integra LifeSciences' liquidity, profitability, solvency, and operating efficiency, Integra LifeSciences Holdings is performing exceptionally good at this time. It has a great probability to report excellent financial results in May. Financial strength of Integra LifeSciences is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Integra LifeSciences' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Integra LifeSciences' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. Integra LifeSciences' bond ratings measure its overall creditworthiness, which in many ways corresponds to the cost of borrowing for an issuer. These ratings assign a letter grade to all of Integra LifeSciences' outstanding corporate bonds that indicate their credit quality. We use reports published by private self-sufficient rating services such as Standard & Poor's or Fitch Ratings Inc. to evaluate a bond issuer's financial strength or its ability to pay a bond's principal and interest. Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Integra LifeSciences' financial leverage. It provides some insight into what part of Integra LifeSciences' total assets is financed by creditors.
|
Integra LifeSciences Holdings (IART) is traded on NASDAQ Exchange in USA. It is located in 1100 Campus Road, Princeton, NJ, United States, 08540 and employs 3,946 people. Integra LifeSciences is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.31 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Integra LifeSciences's market, we take the total number of its shares issued and multiply it by Integra LifeSciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Integra LifeSciences conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 78.6 M outstanding shares of which 2.09 M shares are currently shorted by private and institutional investors with about 2.27 trading days to cover.
Integra LifeSciences Holdings currently holds about 451.52 M in cash with 139.96 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.41.
Check Integra LifeSciences Probability Of Bankruptcy
Ownership AllocationIntegra LifeSciences Holdings has a total of 78.6 Million outstanding shares. The majority of Integra LifeSciences outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Integra LifeSciences to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Integra LifeSciences Holdings. Please pay attention to any change in the institutional holdings of Integra LifeSciences as this could imply that something significant has changed or is about to change at the company. Also note that almost two million three hundred fifty-eight thousand sixty-six invesors are currently shorting Integra LifeSciences expressing very little confidence in its future performance.
Check Integra Ownership Details
Integra Stock Price Odds Analysis
Attributed to a normal probability distribution, the odds of Integra LifeSciences jumping above the current price in 90 days from now is roughly 96.0%. The Integra LifeSciences Holdings probability density function shows the probability of Integra LifeSciences stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 1.4301. This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Integra LifeSciences will likely underperform. Additionally, integra LifeSciences Holdings has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Integra LifeSciences to move above the current price in 90 days from now is roughly 96.0 (This Integra LifeSciences Holdings probability density function shows the probability of Integra Stock to fall within a particular range of prices over 90 days) .
Integra Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Integra LifeSciences that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Integra LifeSciences' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Integra LifeSciences' value.Instituion | Recorded On | Shares | |
Goldman Sachs Group Inc | 2023-12-31 | 1.3 M | |
Geode Capital Management, Llc | 2023-12-31 | 1.3 M | |
Deerfield Management Co | 2023-09-30 | 1.1 M | |
Madison Avenue Partners, Lp | 2023-12-31 | 1 M | |
Point72 Asset Management, L.p. | 2023-09-30 | 905.1 K | |
Macquarie Group Ltd | 2023-12-31 | 889.4 K | |
Fuller & Thaler Asset Management Inc | 2023-12-31 | 841.1 K | |
Manufacturers Life Insurance Co | 2023-12-31 | 715.3 K | |
Gw&k Investment Management, Llc | 2023-12-31 | 693.6 K | |
Vanguard Group Inc | 2023-12-31 | 7 M | |
Blackrock Inc | 2023-12-31 | 6.6 M |
Integra LifeSciences Historical Income Statement
Integra LifeSciences Holdings Income Statement is one of the three primary financial statements used for reporting Integra's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Integra LifeSciences revenue and expense. Integra LifeSciences Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Integra LifeSciences' Net Income Applicable To Common Shares is comparatively stable compared to the past year. Net Income From Continuing Ops is likely to gain to about 75.5 M in 2024, whereas Total Operating Expenses is likely to drop slightly above 383.8 M in 2024. View More FundamentalsIntegra Stock Against Markets
Picking the right benchmark for Integra LifeSciences stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Integra LifeSciences stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Integra LifeSciences is critical whether you are bullish or bearish towards Integra LifeSciences Holdings at a given time. Please also check how Integra LifeSciences' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Integra LifeSciences without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Companies Directory Now
Companies DirectoryEvaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |
All Next | Launch Module |
Integra LifeSciences Corporate Directors
Integra LifeSciences corporate directors refer to members of an Integra LifeSciences board of directors. The board of directors generally takes responsibility for the Integra LifeSciences' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Integra LifeSciences' board members must vote for the resolution. The Integra LifeSciences board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.Richard Caruso | Founder and Director | Profile | |
James Sullivan | Independent Director | Profile | |
Christian Schade | Independent Director | Profile | |
Raymond Murphy | Independent Director | Profile |
How to buy Integra Stock?
Before investing in Integra LifeSciences, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Integra LifeSciences. To buy Integra LifeSciences stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Integra LifeSciences. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Integra LifeSciences stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Integra LifeSciences Holdings stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Integra LifeSciences Holdings stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Integra LifeSciences Holdings, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Integra Stock please use our How to Invest in Integra LifeSciences guide.
Already Invested in Integra LifeSciences Holdings?
The danger of trading Integra LifeSciences Holdings is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Integra LifeSciences is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Integra LifeSciences. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Integra LifeSciences is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Integra LifeSciences is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Integra Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Integra Lifesciences Holdings Stock. Highlighted below are key reports to facilitate an investment decision about Integra Lifesciences Holdings Stock: Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Integra LifeSciences Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Complementary Tools for Integra Stock analysis
When running Integra LifeSciences' price analysis, check to measure Integra LifeSciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integra LifeSciences is operating at the current time. Most of Integra LifeSciences' value examination focuses on studying past and present price action to predict the probability of Integra LifeSciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integra LifeSciences' price. Additionally, you may evaluate how the addition of Integra LifeSciences to your portfolios can decrease your overall portfolio volatility.
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Transaction History View history of all your transactions and understand their impact on performance | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |
Is Integra LifeSciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Integra LifeSciences. If investors know Integra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Integra LifeSciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.60) | Earnings Share 0.84 | Revenue Per Share 19.248 | Quarterly Revenue Growth (0) | Return On Assets 0.0424 |
The market value of Integra LifeSciences is measured differently than its book value, which is the value of Integra that is recorded on the company's balance sheet. Investors also form their own opinion of Integra LifeSciences' value that differs from its market value or its book value, called intrinsic value, which is Integra LifeSciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Integra LifeSciences' market value can be influenced by many factors that don't directly affect Integra LifeSciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Integra LifeSciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Integra LifeSciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Integra LifeSciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.